Preclinical toxicology studies are key for future therapeutics being safely brought to market. AmplifyBio offers toxicology services with strategic input from proof-of-concept studies to advanced FDA GLP regulated studies, including small molecule studies. Ensure therapeutic programs are relevant and applicable with guidance and insights from our knowledgeable multidisciplinary team. Our experienced team of toxicologists are willing to be supportive partners from study design to study interruption. Contact AmplifyBio to initiate your preclinical toxicology studies.
AmplifyBio offers in vivo preclinical toxicology services with supportive, technical, and strategic input from proof-of-concept studies to advanced FDA GLP regulated studies. Tell us your goals; we will help you design the path.
Our experts have cultivated decades of experience as members of the Battelle organization, and since AmplifyBio’s spin-out in 2021, we’ve added to our expertise innovative tools and laboratories to meet commercially focused goals.
Some of our additional services
Amplifybio couples dedicated testing and related preclinical CRO services with a skilled team and access to the latest resources. The combination produces groundbreaking research for specialty products, multi-species exposures, and assessments that can be analyzed for implementation in produces and processes. Talk with us about your individual requirements and work with our specialists to develop an effective analysis.